retatrutide liver damage and fatty study Researchers report promising results with retatrutide, which significantly reduced fat in some patients over several months. Excess liver fat causes metabolic dysfunction–associated steatotic liver disease (MASLD Experimental weight-loss drug slashed fat

2006;176(4 Pt 1):1307-1312

Mechanistic insights into the catalytic reaction of ferulic acid decarboxylase from aspergillus Niger: a QM/MM study

Production of L-Carnitine Production: Your body naturally produces L-carnitine, primarily in the liver and kidneys, from the amino acids lysine and methionine

Bone Density Assessment DEXA can also measure bone health and screen for conditions such as Osteopenia and Osteoporosis

A New Maintenance Strategy After GLP Injections Oral GLP-1 maintenance after injectable weight loss Eli Lilly has reported positive topline Phase 3 results from ATTAIN-MAINTAIN, a trial designed to answer a very practical question: after achieving weight loss on injectable therapies, can patients maintain that loss by switching to a once-daily oral GLP-1